Clinical Trial Update: Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sino-nasal inhaled colistin in cystic fibrosis patients with Pseudomonas aeruginosa colonization has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Colistin (colistin)

Snippet

Sponsor: University of Jena | Conditions: Cystic Fibrosis, Pseudomonas Aeruginosa | Phase 2 | Status: COMPLETED